Apop stock price target
Nov 06, 2019 · Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. APOP | Cellect Biotechnology Ltd. ADR Overview | MarketWatch 7:59a Abbot Labs stock price target cut to $88 from $101 at J.P. Morgan Cellect Biotechnology Ltd. ADR. Cellect Biotechnology Ltd. engages in the provision of regenerative medicine. Its APOP | Cellect Biotechnology Ltd. ADR Analyst Estimates ...
APOP Stock Soars 50% on a Major Deal with Canndoc
Stock analysis for Cellect Biotechnology Ltd (APOP) including stock price, stock chart, company news, key statistics, fundamentals and company profile. Latest Fundamentals:: Cellect Biotechnology Ltd., (NASDAQ ... 4 days ago · APOP stock construct a change of 42.75 in a total of its share price and finished its trading at 1.97. Cellect Biotechnology Ltd. institutional ownership is held at 0.00% while insider ownership was 54.73%. As of now, APOP has a P/S, P/E and P/B values of … At Cellect Biotechnology Ltd. (NASDAQ:APOP), the Share ... Mar 05, 2020 · 1 out of 1 analysts covering the stock have rated it a Buy, while 0 have maintained a Hold recommendation on Cellect Biotechnology Ltd.. 0 analysts has assigned a Sell rating on the APOP stock. The 12-month mean consensus price target for the company’s shares has been set at $12.00. Cellect Biotechnology Ltd. (APOP) turns bullish with gain ... Mar 05, 2020 · The APOP stock was last observed hovering at around $2.07 in the last trading session, with the day’s gains setting it 0.96% off its average median price target of $3.00 for the next 12 months. It is also -1.0% off the consensus price target high of $3.00 offered by 1 analysts, but current levels are -1.0% lower than the price target low of
Latest Fundamentals:: Cellect Biotechnology Ltd., (NASDAQ ...
Mar 06, 2020 · Investment analysts at BofA/Merrill published a research note on December 19, 2019 where it informed investors and clients that Sealed Air Corporation (NYSE:SEE) is now rated as Buy. Their price target on the stock stands at $51. Even though the stock has been trading at $31.28/share, analysts expect it to down by -5.05% to reach $44.09/share. APOP Stock Quote - Cellect Biotechnology Ltd - Bloomberg ... Stock analysis for Cellect Biotechnology Ltd (APOP) including stock price, stock chart, company news, key statistics, fundamentals and company profile. Latest Fundamentals:: Cellect Biotechnology Ltd., (NASDAQ ... 4 days ago · APOP stock construct a change of 42.75 in a total of its share price and finished its trading at 1.97. Cellect Biotechnology Ltd. institutional ownership is held at 0.00% while insider ownership was 54.73%. As of now, APOP has a P/S, P/E and P/B values of … At Cellect Biotechnology Ltd. (NASDAQ:APOP), the Share ... Mar 05, 2020 · 1 out of 1 analysts covering the stock have rated it a Buy, while 0 have maintained a Hold recommendation on Cellect Biotechnology Ltd.. 0 analysts has assigned a Sell rating on the APOP stock. The 12-month mean consensus price target for the company’s shares has been set at $12.00.
Stock analysis for Cellect Biotechnology Ltd (APOP) including stock price, stock chart, company news, key statistics, fundamentals and company profile.
Apr 01, 2020 · Illiquidity is an inherent risk associated with investing in real estate and REITs. There is no guarantee the issuer of a REIT will maintain the secondary market for its shares and redemptions may be at a price which is more or less than the original price paid. Closed-end … APOP Cellect Biotechnology Ltd. Stock Quote Cellect Biotechnology Ltd., a biotechnology company, engages in developing ApoGraft, a technology platform that functionally selects stem cells to enhance the safety of regenerative medicine and stem cell therapies in Israel. APOP Stock Quote - Cellect Biotechnology Ltd. American ... Mar 30, 2020 · Stock quote for Cellect Biotechnology Ltd. American Depositary Shares Common Stock (APOP) with real-time last sale and extended hours stock … Cellect Biotechnology Ltd. - APOP - Stock Price Today - Zacks
Vapotherm has a consensus price target of $23.00, suggesting a potential upside of 42.86%. Given Vapotherm’s higher possible upside, analysts clearly believe Vapotherm is more favorable than CELLECT BIOTECH/S. Volatility and Risk. CELLECT BIOTECH/S has a beta of 1.53, meaning that its share price is 53% more volatile than the S&P 500.
Cellect Biotechnology Ltd (APOP) Cellect Biotechnology Ltd (APOP) [[ item.lastPrice ]] It is based on a 60-month historical regression of the return on the stock onto the return on the S&P 500. Price/Sales: Latest closing price divided by the last 12 months of revenue/sales per share. Cellect Biotechnology Ltd. American ... - Nasdaq Stock Market
APOP Stock Price & Charts | Cellect Biotechnology In depth view into APOP (Cellect Biotechnology) stock including the latest price, news, dividend history, earnings information and financials.